Goldman Sachs’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $22.2M | Buy |
|
|||||
|
2023
Q1 | $13M | Sell |
|
|||||
|
2022
Q4 | $10.4M | Sell |
|
|||||
|
2022
Q3 | $8.74M | Buy |
|
|||||
|
2022
Q2 | $2.32M | Sell |
|
|||||
|
2022
Q1 | $3.52M | Sell |
|
|||||
|
2021
Q4 | $31.2M | Buy |
|
|||||
|
2021
Q3 | $17.8M | Buy |
|
|||||
|
2021
Q2 | $8.76M | Sell |
|
|||||
|
2021
Q1 | $23.1M | Sell |
|
|||||
|
2020
Q4 | $28.8M | Sell |
|
|||||
|
2020
Q3 | $30.2M | Buy |
|
|||||
|
2020
Q2 | $43.8M | Buy |
|
|||||
|
2020
Q1 | $24.9M | Buy |
|
|||||
|
2019
Q4 | $33.1M | Buy |
|
|||||
|
2019
Q3 | $10.4M | Buy |
|
|||||
|
2019
Q2 | $7.47M | Sell |
|
|||||
|
2019
Q1 | $7.04M | Buy |
|
|||||
|
2018
Q4 | $2.46M | Buy |
|
|||||
|
2018
Q3 | $1.99M | Sell |
|
|||||
|
2018
Q2 | $1.06M | Buy |
|
|||||
|
2018
Q1 | $604K | Buy |
|
|||||
|
2017
Q4 | $307K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $225K | Sell |
|
|||||
|
2016
Q2 | $1.09M | Buy |
|